Health Care & Life Sciences » Pharmaceuticals | Samjin Pharmaceutical Co. Ltd.

Samjin Pharmaceutical Co. Ltd. | Mutual Funds

Mutual Funds that own Samjin Pharmaceutical Co. Ltd.

Name
Shares Held
% Shares Out
Change In Shares
% of Assets
As of Date
Aviva Investors - Emerging Markets Equity Small Cap Fund
232,146
1.67%
0
3.1%
06/30/2018
220,537
1.59%
220,537
0.19%
04/15/2017
iShares Core MSCI Emerging Markets ETF
165,596
1.19%
0
0.02%
09/05/2018
Fidelity Funds SICAV - Asian Smaller Companies Fund
101,603
0.73%
-40,777
0.63%
05/31/2018
DFA Emerging Markets Core Equity Portfolio
96,586
0.7%
0
0.02%
04/30/2018
DFA Emerging Markets Small Cap Series
82,503
0.59%
0
0.06%
01/31/2018
77,559
0.56%
0
0.32%
03/31/2018
Fidelity Emerging Markets Discovery Fund
69,641
0.5%
-15,687
0.97%
07/31/2018
Government Pension Fund - Global (The)
63,781
0.46%
-22,620
0%
12/31/2017
58,000
0.42%
0
0.3%
03/31/2018

About Samjin Pharmaceutical Co.

View Profile
Address
121 Wausan-ro
Seoul SL 04054
Korea, Republic Of
Employees -
Website http://www.samjinpharm.co.kr
Updated 07/08/2019
Samjin Pharmaceutical Co., Ltd. engages in the manufacture, distribution, and sale of pharmaceutical products. Its products include tablets, capsules, and shots. The company was founded on April 18, 1968 and is headquartered in Seoul, South Korea.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.